2/2
10:02 am
osrh
CEO Statement to Shareholders [Yahoo! Finance]
High
Report
CEO Statement to Shareholders [Yahoo! Finance]
1/22
09:55 am
osrh
Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial Launch
Medium
Report
Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial Launch
1/16
09:32 am
osrh
Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform [Yahoo! Finance]
Low
Report
Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform [Yahoo! Finance]
1/16
09:20 am
osrh
Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform
Medium
Report
Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform
1/12
08:05 am
osrh
Vaximm, an OSR Company, Receives Binding Term Sheet from BCM Europe for Global Exclusive License of VXM01 with $30M Upfront and Up to $815M in Milestones
Low
Report
Vaximm, an OSR Company, Receives Binding Term Sheet from BCM Europe for Global Exclusive License of VXM01 with $30M Upfront and Up to $815M in Milestones
12/19
12:26 pm
osrh
Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings [Yahoo! Finance]
Low
Report
Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings [Yahoo! Finance]
12/19
11:50 am
osrh
Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings
High
Report
Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings
12/10
04:10 am
osrh
OSR (NASDAQ:OSRH) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
OSR (NASDAQ:OSRH) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
12/9
07:00 am
osrh
Presenting on Emerging Growth Conference 88 Day 1 on December 10; Register to live stream
Medium
Report
Presenting on Emerging Growth Conference 88 Day 1 on December 10; Register to live stream
12/4
03:22 pm
osrh
Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target Following Major Licensing Agreement [Yahoo! Finance]
Low
Report
Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target Following Major Licensing Agreement [Yahoo! Finance]
12/3
04:32 pm
osrh
OSR (NASDAQ:OSRH) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
OSR (NASDAQ:OSRH) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
12/3
04:51 am
osrh
Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months [Yahoo! Finance]
High
Report
Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months [Yahoo! Finance]
12/2
09:53 am
osrh
Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months
Low
Report
Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months
12/1
04:11 pm
osrh
OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025 [Yahoo! Finance]
Medium
Report
OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025 [Yahoo! Finance]
12/1
03:01 pm
osrh
OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025
Medium
Report
OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025
11/27
02:52 pm
osrh
OSR (NASDAQ:OSRH) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
High
Report
OSR (NASDAQ:OSRH) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.